| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Endocrinology Division, Department of Pediatrics The University of Virginia Charlottesville, Virginia 22901
2 Reprint requests Dr. Alan D. Rogol, Dept. of Pediatrics, University of Virginia Medical School, Charlottesville, VA 2901
TRH-stimulated prolactin release was determined in four male volunteers with and without pre-treatment with cyproheptadine All showed a marked increase in the TRH-mediated prolactin rise and a marked decrease in the TRH-mediated TSH rise when receiving cyproheptadine pre-treatment.
3 Supported by Grants HD 08926 (NICHHD); RR847 (Division of Research Resources, NIH).
Received July 16, 1976.
This article has been cited by other articles:
![]() |
J. WORTSMAN, N. G. SOLER, and J. HIRSCHOWITZ Cyproheptadine in the Management of the Galactorrhea-Amenorrhea Syndrome Ann Intern Med, June 1, 1979; 90(6): 923 - 925. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |